相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Ambulatory Monitoring of Heart Sounds via an Implanted Device Is Superior to Auscultation for Prediction of Heart Failure Events
Michael Cao et al.
JOURNAL OF CARDIAC FAILURE (2020)
Modifiable risk factors predict incident atrial fibrillation and heart failure
Jorge A. Wong et al.
OPEN HEART (2020)
Preliminary experience with the multisensor HeartLogic algorithm for heart failure monitoring: a retrospective case series report
Alessandro Capucci et al.
ESC HEART FAILURE (2019)
HeartLogic Multisensor Algorithm Identifies Patients During Periods of Significantly Increased Risk of Heart Failure Events Results From the MultiSENSE Study
Roy S. Gardner et al.
CIRCULATION-HEART FAILURE (2018)
Utility and limitations of long-term monitoring of atrial fibrillation using an implantable loop recorder
Randall Lee et al.
HEART RHYTHM (2018)
Progression of Device-Detected Subclinical Atrial Fibrillation and the Risk of Heart Failure
Jorge A. Wong et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Catheter Ablation for Atrial Fibrillation with Heart Failure
Nassir F. Marrouche et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Device-detected subclinical atrial tachyarrhythmias: definition, implications and management-an European Heart Rhythm Association (EHRA) consensus document, endorsed by Heart RhythmSociety (HRS), Asia Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE)
Bulent Gorenek et al.
EUROPACE (2017)
Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT
Isabelle C. Van Gelder et al.
EUROPEAN HEART JOURNAL (2017)
Type of Atrial Fibrillation and Outcomes in Patients With Heart Failure and Reduced Ejection Fraction
Ulrik M. Mogensen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Treatment of Patients With Atrial Fibrillation and Heart Failure With Reduced Ejection Fraction
Atul Verma et al.
CIRCULATION (2017)
Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation Vicious Twins
Dipak Kotecha et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fibrillation: a cohort study
Jeff S. Healey et al.
LANCET (2016)
Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis
Ayodele Odutayo et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis
Ayodele Odutayo et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Incidence of Atrial Fibrillation and Relationship With Cardiovascular Events, Heart Failure, and Mortality A Community-Based Study From the Netherlands
Rob A. Vermond et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
New-onset Atrial Fibrillation Predicts Heart Failure Progression
Ryan G. Aleong et al.
AMERICAN JOURNAL OF MEDICINE (2014)
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
Craig T. January et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
2013 ACCF/AHA Guideline for the Management of Heart Failure A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Clyde W. Yancy et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Subclinical Atrial Fibrillation and the Risk of Stroke
Jeff S. Healey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Apixaban versus Warfarin in Patients with Atrial Fibrillation
Christopher B. Granger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
Manesh R. Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
Stuart J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation
Robert G. Hart et al.
ANNALS OF INTERNAL MEDICINE (2007)
Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction - Results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and Morbidity (CHARM) program
Lars G. Olsson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function - A report from the Acute Decompensated Heart Failure National Registry (ADHERE) database
CW Yancy et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Predictors of mortality and morbidity in patients with chronic heart failure
SJ Pocock et al.
EUROPEAN HEART JOURNAL (2006)
Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with betablockers: Results from COMET
K Swedberg et al.
EUROPEAN HEART JOURNAL (2005)